TNF and COVID-19: NK cells derived from COVID-19 patients, besides being reduced in number, also exhibit limited anti-viral activity and are characterized by an increased expression of the NK inhibitory marker NKG2A, which limits the production of effector molecules, such as CD107a, IFN-γ, IL-2, granzyme B, and TNF-α [81].